2023-10-04 09:41:19
TAKEDA – Latin Clinical Trial Center

TAKEDA

By June 19, 2019 Closed

A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared with Valsartan and Olmesartan in Subjects with Essential Hypertension

Join the discussion 7 Comments

Leave a Reply